Maria Balda ,
-
Aurora Bay Area Prices – SELECTIVE CATH 2ND ORDER RENAL BILAT is $8,150.00
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10004465, regarding SELECTIVE CATH 2ND ORDER RENAL BILAT, which is classified under revenue code 360 and associated with CPT code 36254, the designated fee stands at $8,150.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Bay Area Prices – TREATMENT DEVICE, COMPLEX is $1,980.00
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10003790, regarding TREATMENT DEVICE, COMPLEX, which is classified under revenue code 333 and associated with CPT code 77334, the designated fee stands at $1,980.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Bay Area Prices – ELECTRON MICROSCOPY KIDNEY is $1,860.00
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10001791, regarding ELECTRON MICROSCOPY KIDNEY, which is classified under revenue code 310 and associated with CPT code 88348, the designated fee stands at $1,860.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Immunodeficiency Disorders in Children: Diagnosis and Management
In conclusion, early diagnosis and tailored management of immunodeficiency disorders in children are paramount for improving outcomes and quality of life. Advances in genetic testing and targeted therapies offer promising avenues for more precise and effective treatments. However, ongoing research and interdisciplinary collaboration remain essential to address the complexities of these conditions. By fostering a comprehensive approach that includes patient education, regular monitoring, and supportive care, healthcare providers can significantly enhance the prognosis for affected children.
